These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 583025)
1. The interaction of adriamycin with small unilamellar vesicle liposomes. A fluorescence study. Karczmar GS; Tritton TR Biochim Biophys Acta; 1979 Nov; 557(2):306-19. PubMed ID: 583025 [TBL] [Abstract][Full Text] [Related]
2. Effects of adriamycin on lipid polymorphism in cardiolipin-containing model and mitochondrial membranes. Nicolay K; van der Neut R; Fok JJ; de Kruijff B Biochim Biophys Acta; 1985 Sep; 819(1):55-65. PubMed ID: 4041451 [TBL] [Abstract][Full Text] [Related]
3. On the reversal by deoxyribonucleic acid of the binding of adriamycin to cardiolipin-containing liposomes. Mustonen P; Kinnunen PK J Biol Chem; 1993 Jan; 268(2):1074-80. PubMed ID: 7678246 [TBL] [Abstract][Full Text] [Related]
4. Interaction of Ca2+ with cardiolipin-containing liposomes and its inhibition by adriamycin. Brenza JM; Neagle CE; Sokolove PM Biochem Pharmacol; 1985 Dec; 34(24):4291-8. PubMed ID: 4074389 [TBL] [Abstract][Full Text] [Related]
5. Adriamycin inhibits the formation of non-bilayer lipid structures in cardiolipin-containing model membranes. Goormaghtigh E; Vandenbranden M; Ruysschaert JM; De Kruijff B Biochim Biophys Acta; 1982 Feb; 685(2):137-43. PubMed ID: 6277379 [TBL] [Abstract][Full Text] [Related]
6. Localization of adriamycin in model and natural membranes. Influence of lipid molecular packing. Dupou-Cézanne L; Sautereau AM; Tocanne JF Eur J Biochem; 1989 May; 181(3):695-702. PubMed ID: 2731543 [TBL] [Abstract][Full Text] [Related]
7. The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes. Nicolay K; Timmers RJ; Spoelstra E; Van der Neut R; Fok JJ; Huigen YM; Verkleij AJ; De Kruijff B Biochim Biophys Acta; 1984 Dec; 778(2):359-71. PubMed ID: 6498197 [TBL] [Abstract][Full Text] [Related]
8. Binding of adriamycin to liposomes as a probe for membrane lateral organization. Söderlund T; Jutila A; Kinnunen PK Biophys J; 1999 Feb; 76(2):896-907. PubMed ID: 9929491 [TBL] [Abstract][Full Text] [Related]
9. Anthracycline binding to synthetic and natural membranes. A study using resonance energy transfer. Griffin EA; Vanderkooi JM; Maniara G; Erecińska M Biochemistry; 1986 Dec; 25(24):7875-80. PubMed ID: 3467794 [TBL] [Abstract][Full Text] [Related]
10. Interaction of adriamycin with negatively charged model membranes: evidence of two types of binding sites. Henry N; Fantine EO; Bolard J; Garnier-Suillerot A Biochemistry; 1985 Dec; 24(25):7085-92. PubMed ID: 4084563 [TBL] [Abstract][Full Text] [Related]
11. Doxorubicin inhibits the phosphate-transport protein reconstituted in liposomes. A study on the mechanism of the inhibition. Müller M; Cheneval D; Carafoli E Eur J Biochem; 1984 May; 140(3):447-52. PubMed ID: 6723644 [TBL] [Abstract][Full Text] [Related]
12. Surface plasmon resonance studies of complex formation between cytochrome c and bovine cytochrome c oxidase incorporated into a supported planar lipid bilayer. II. Binding of cytochrome c to oxidase-containing cardiolipin/phosphatidylcholine membranes. Salamon Z; Tollin G Biophys J; 1996 Aug; 71(2):858-67. PubMed ID: 8842224 [TBL] [Abstract][Full Text] [Related]
13. Phase Equilibria in binary mixtures of dimyristoylphosphatidylcholine and cardiolipin. Berclaz T; McConnell HM Biochemistry; 1981 Nov; 20(23):6635-40. PubMed ID: 6272842 [TBL] [Abstract][Full Text] [Related]
14. Membrane fusion and the lamellar-to-inverted-hexagonal phase transition in cardiolipin vesicle systems induced by divalent cations. Ortiz A; Killian JA; Verkleij AJ; Wilschut J Biophys J; 1999 Oct; 77(4):2003-14. PubMed ID: 10512820 [TBL] [Abstract][Full Text] [Related]
15. Reversible, nonionic, and pH-dependent association of cytochrome c with cardiolipin-phosphatidylcholine liposomes. Rytömaa M; Mustonen P; Kinnunen PK J Biol Chem; 1992 Nov; 267(31):22243-8. PubMed ID: 1331048 [TBL] [Abstract][Full Text] [Related]
16. Interaction of adriamycin with cardiolipin-containing vesicles. Evidence of an embedded site for the dihydroanthraquinone moiety. Fiallo MM; Garnier-Suillerot A Biochim Biophys Acta; 1986 Jan; 854(1):143-6. PubMed ID: 3002460 [TBL] [Abstract][Full Text] [Related]
17. Location and dynamics of anthracyclines bound to unilamellar phosphatidylcholine vesicles. Burke TG; Tritton TR Biochemistry; 1985 Oct; 24(21):5972-80. PubMed ID: 3866609 [TBL] [Abstract][Full Text] [Related]
18. Adriamycin as a probe for the transversal distribution of cardiolipin in the inner mitochondrial membrane. Cheneval D; Müller M; Toni R; Ruetz S; Carafoli E J Biol Chem; 1985 Oct; 260(24):13003-7. PubMed ID: 4055730 [TBL] [Abstract][Full Text] [Related]
19. A comparative model membrane study on structural effects of membrane-active positively charged anti-tumor drugs. Nicolay K; Sautereau AM; Tocanne JF; Brasseur R; Huart P; Ruysschaert JM; de Kruijff B Biochim Biophys Acta; 1988 May; 940(2):197-208. PubMed ID: 3163502 [TBL] [Abstract][Full Text] [Related]
20. Coverage-dependent changes of cytochrome c transverse location in phospholipid membranes revealed by FRET. Domanov YA; Molotkovsky JG; Gorbenko GP Biochim Biophys Acta; 2005 Oct; 1716(1):49-58. PubMed ID: 16183372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]